Vivek Ahuja Email and Phone Number
Vivek Ahuja work email
- Valid
- Valid
- Valid
- Valid
- Valid
Vivek Ahuja personal email
- Valid
Vivek Ahuja phone numbers
Dr. Vivek Ahuja, a physician with a background in business administration, is a pioneer in the field of pharmacovigilance since 2001. He established India's first global pharmacovigilance unit at Ranbaxy and has over 24 years of experience across diverse areas including pharmacovigilance, clinical research, public health, and technology. His expertise extends to global pharmacovigilance regulations, collaboration with regulatory authorities, and technology-related insights. Vivek brings hands-on experience and insights in the areas of drugs, vaccines, biologics & devices safety. Prior to joining EVERSANA, Dr. Vivek Ahuja was VP – Medical Affairs & Global Head of Pharmacovigilance at Sun Pharma. His responsibilities include managing the Global Pharmacovigilance function with teams from US, EU, Japan, South Africa and India supporting him to maintain compliance to global regulations. Prior to this, he worked at a global technology company i.e. ArisGlobal, where he was VP for Global Pharmacovigilance and headed the safety business unit. His responsibilities included strategy, operations, managing the profit and loss of this software technology business. Prior to joining ArisGlobal, Vivek worked as Director, Research and Development at PATH a Seattle based international nonprofit organization working to accelerate health equity. He was overseeing PATH’s work of driving transformative global health innovation to save and improve lives, PATH is also the world’s largest public health partner to the Bill & Melinda Gates foundation. Dr. Ahuja did his MBBS from Government Medical College, Chandigarh, India & MD from AIIMS, New Delhi. He is also an Executive MBA from one of the leading Business Schools in India (Management Development Institute, Gurgaon). Vivek actively contributes to policy-making for the government. In particular, he co-authored the Pharmacovigilance Program of India (Government of India) in 2010 and supported the Nepal and Bangladesh governments by conceptualizing focused pharmacovigilance programs for neglected drugs. In China, he helped establish the vaccine safety systems of the largest government vaccine manufacturer. He has an avid interest in technology and its applications, particularly cognitive computing. Vivek is a governing council member of the Sun Pharma Community Healthcare Society. He is on the Editorial Advisory Board of Pharma Focus Asia, comprising industry thought leaders with wide-ranging experience, expertise and significant contributions to the pharmaceutical industry.
Eversana
View- Website:
- eversana.com
- Employees:
- 4677
-
Senior Vp -Global Delivery Excellence, Strategy And Growth (Pv, Quality, Regulatory Services)EversanaGurugram, Hr, In
-
Senior Vp -Global Delivery Excellence, Strategy & Growth (Pv, Quality, Regulatory Services)Eversana Apr 2023 - PresentChicago, Il, UsWith over 22 years of experience across multiple functional offerings including Pharmacovigilance, Clinical Research, Technology, and Public Health, Vivek will lead this role at Eversana. A physician by education (MD) with training in business administration (MBA) and a seasoned professional in the pharmaceutical industry, Dr. Vivek Ahuja pioneered the introduction of pharmacovigilance as a subject and science in India in the year 2003. Having been in a global role for the past 17 years of his career he has experience in working in worldwide pharmacovigilance regulations related to drugs, vaccines and devices.Prior to joining EVERSANA, he was Vice President for Medico-Regulatory Affairs, Clinical Data Research & Global Head of Pharmacovigilance at Sun Pharma, the 4th largest global generics company and the largest of its kind in India. With his vision he established the country’s first global pharmacovigilance unit in the country’s largest pharmaceutical company and scaled up several such organizations in this field. He has been actively involved in policymaking efforts for many years in the region, including co-authoring the National Pharmacovigilance Program of India in 2010 and supported the Nepal and Bangladesh governments in developing focused pharmacovigilance programs for neglected drugs.Vivek will spearhead the global pharmacovigilance, quality and regulatory solutions at EVERSANA. Vivek is passionate about the applications of AI, ML and NLP and wants to make a significant difference to the business using these capabilities.
-
Editorial Advisory Board Of Pharma Focus AsiaPharma Focus Asia Magazine 2023 - PresentHyderabad, Telangana, InPharmafocus Asia is a magazine and online publication that focuses on the pharmaceutical and healthcare industries in the Asia-Pacific region. -
Governing Council MemberSun Pharmaceutical Community Healthcare Society 2021 - Present
-
Head Global Pharmacovigilance & Vice President Medico-Regulatory Affairs & Clinical Data ReportingSun Pharma Dec 2018 - Apr 2023Mumbai, Maharastra, InResponsible for Medical Writing, Clinical Data Management & Global Pharmacovigilance functions -
Vice President, Global PharmacovigilanceArisglobal Feb 2016 - Nov 2018Waltham, Massachusetts, UsStrategy execution and thought leader for ArisGlobal, accountable for successful development and implementation of business and operations strategies for engaging regulatory agencies and other health authorities globally. Also contribute to the line-of-business strategic and innovation agenda for taking the company to scale. -
Director, Research And DevelopmentPath Mar 2013 - Jan 2016Seattle, Wa, UsStrategic and operational oversight of multiple projects across South Asia both in upstream and downstream activities in public health. Projects vary from technology advancement support, operational research to clinical research to capacity building and advocacy in close collaboration with government partners and other public health organizations.• Conceptualized and co-developed a health technology transformation portfolio - a partnership model with incubators/accelerators to support local innovators, accelerating the rate at which health-related devices and diagnostics are developed, introduced, and scaled to meet the needs of people in resource-limited communities. • Operational and clinical research projects related to Visceral Leishmaniasis, Post Kala Azar Dermal Leishmaniasis (PKDL) in South Asia. Led a global scientific consortium on PKDL. • Conceptualized and leading the execution of a project on Clinical research capacity building in India working with partners like DBT. Built a national brand called ‘CReATE’ through a unique public-private partnership model. Conceptualized and co-developed 6 softwares in the area of research that would serve as sustainable pro bono resources for all researchers.• Designing and executing focused pharmacovigilance programs for a neglected disease for governments of Bangladesh, India and Nepal. • Envisioned, established and operationalizing vaccine safety systems of CDIBP, China - manufacturer of Japanese Encephalitis vaccine. • Conceptualized a project on strengthening government health facilities to reduce death among encephalopathy and Acute Encephalitis Syndrome cases in Bihar and UP, through reinforcement of better case management practices.• Instrumental role in designing the strategy blueprint for the PATH India 2.0 strategy. A complex exercise involving a deep understanding of the local and international donor space, the country’s needs as a customer, and our own institutional strengths. -
Director - Pharmacovigilance, Asia PacificBaxter Heathcare Jan 2010 - Dec 2012Deerfield, Illinois, UsResponsible for driving the strategic direction, operating and maintaining a high performing Pharmacovigilance function for Baxter in Asia-Pacific with an annual budget of ~2 Million $. • Responsibilities included - ensuring compliance to the regulatory expectations of 15 countries in Asia Pac – including Japan and Australia. •Team comprised of ~27 people (plus 15 outsourced resources) with presence in each of these 15 countries. Including a team of 11 people based in Japan. • Established a sustainable model for the Japan pharmacovigilance work, ensuring that the increasing demands of manpower were managed in a more efficient manner and therefore in alignment with the business growth.• Day-to-day operational management and strategic oversight to the Region, own regional editions of Global projects, identify, conceptualize and drive new initiatives in the Region for improving efficiency and save increasing costs and resource requirements.• Ensuring inspection readiness for regulatory inspection in the countries. Facing regulatory inspections as required and interact with the regulatory agency for product safety issues.• Consult, inform and interact with the various other departments in the organization which have touch points with the Pharmacovigilance function. Participate in leadership teams at various levels in the organization, to ensure Pharmacovigilance representation from Asia Pacific.• Manage regional pharmacovigilance budget and resources -
Director, Clinical Operations, Cdm & PharmacovigilanceGvk Biosciences Feb 2009 - Dec 2009Hyderabad, Telangana, In• Responsible for managing global clinical studies from many amongst the top 5 global pharma. The therapeutic areas that he worked for included Neglected diseases (Visceral Leishmaniasis, Malaria etc.), Oncology, Neurology, Cardiology etc.• Oversee the operational aspects of the domains of clinical operations, clinical data management and pharmacovigilance. Overseeing at least ten global clinical studies, with sites in India.• Institute and implement systems, processes and metrics for operations in the various domains of business through instruments of policy, standard operating procedures, and technology tools.• Maintain focus on customers in terms of responsiveness, reporting and feedback to exceed customer expectations and attain high levels of customer satisfaction.• Support the growth of the business by adding new clients, attracting new business from existing clients, and exploring and executing the development of new lines of business. -
Section Head, Medical Affairs & Clinical Research, Global Head, Corporate PharmacovigilanceRanbaxy Jan 2005 - Feb 2009Gurgaon, Haryana, In• Established the global pharmacovigilance function, responsibilities included management & operational oversight of the pharmacovigilance teams based in US (10 resources) and EU (15 resources) as also shared resources based in various countries across Latin America, Africa & Asia. • Has to his credit of being the first in India to have established a full service global pharmacovigilance system for an Indian multinational pharmaceutical company.• Conceptualized and operationalizing a successful global pharmacovigilance system which has withstood the test of several FDA, MHRA and other regulatory bodies’ inspections.• Recipient of the Runners up Global Appreciate award for team work and excellence in 2008 (an award for which ~10,000 employees compete annually). • Responsibilities included operational oversight of global adverse drug reaction reporting, Periodic Safety Update Reports submissions, signal detection, product quality complaints management, safety data exchange agreements management, product recall management. • As member secretary of the company’s Product Safety Committee, instrumental in ensuring that pharmacovigilance as a function was accorded the highest level of importance at the top management. • Successfully tested the company’s global electronic safety database for E2B submissions to competent authorities of 27 EU countries and USFDA. As a mark of achievement, at one time Ranbaxy was amongst the only 8 companies to have electronically tested with USFDA on AS2 gateway and was invited to be a member of CDER ePROMPT committee which advises other companies on electronic testing. • Oversight of Phase IIb, III & IV studies in a broad range of therapeutic areas. These include studies for USFDA, EU and DCGI (India) submissions. -
Head, Medical AffairsReliance Clinical Research Services 2003 - 2005• Established the Medical Affairs and Pharmacovigilance Department.• Conceptualized the clinical development strategy for one of the first stem cell therapy product in India. • Core responsibilities included, project management & medical monitoring of clinical trial projects in the area of stem cell based therapies, oncology, orthopedics, cardiology and pharmacovigilance. • Imparting therapeutic area training
-
Head Medical AffairsMorepen Laboratories 2001 - 2003New Delhi, Harayana, In• Oversight of clinical trial projects, medico-marketing, product launches, training on therapeutic areas.
Vivek Ahuja Skills
Vivek Ahuja Education Details
-
All India Institute Of Medical SciencesMd -
Management Development Institute, GurgaonGeneral
-
Government Medical College ChandigarhMedicine
-
Delhi Public School - R. K. PuramBiology
-
St. Theresa'S Convent School KarnalElementary And Middle School Administration/Principalship
Frequently Asked Questions about Vivek Ahuja
What company does Vivek Ahuja work for?
Vivek Ahuja works for Eversana
What is Vivek Ahuja's role at the current company?
Vivek Ahuja's current role is Senior VP -Global Delivery Excellence, Strategy and Growth (PV, Quality, Regulatory Services).
What is Vivek Ahuja's email address?
Vivek Ahuja's email address is vi****@****act.com
What is Vivek Ahuja's direct phone number?
Vivek Ahuja's direct phone number is (206) 285*****
What schools did Vivek Ahuja attend?
Vivek Ahuja attended All India Institute Of Medical Sciences, Management Development Institute, Gurgaon, Government Medical College Chandigarh, Delhi Public School - R. K. Puram, St. Theresa's Convent School Karnal.
What are some of Vivek Ahuja's interests?
Vivek Ahuja has interest in Science And Technology, Health.
What skills is Vivek Ahuja known for?
Vivek Ahuja has skills like Pharmacovigilance, Pharmaceutical Industry, Clinical Research, Cro, Clinical Trials, Medical Affairs, Gcp, Medical Writing, Clinical Development, Management, Public Health, Public Speaking.
Who are Vivek Ahuja's colleagues?
Vivek Ahuja's colleagues are Julie Wagner, Lisbeth Caballero, Ajinkya Askar, Jamia Martin, Christine Muse, Jacqueline Anjo, Rachana D..
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial